Güthlin Corina1, Holmberg Christine2, Gudrun Klein3. 1. Institute of General Practice, Johann Wolfgang Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. guethlin@allgemeinmedizin.uni-frankfurt.de. 2. Berlin School of Public Health, Charité - Universitätsmedizin Berlin, Seestr. 73 - Haus 10, 13347, Berlin, Germany. 3. Institute of General Practice, Johann Wolfgang Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Abstract
PURPOSE: The rising use of complementary and alternative medicine (CAM) means oncologists are increasingly asked by patients to discuss CAM treatment options. However, no formal training or established standards are available on the subject. The aim of this paper was to investigate real-world discussions of CAM treatments. In particular, we wanted to learn about the values, norms and defining features that characterise oncologist-patient discussions on CAM. METHODS: Semi-standardised interviews with 17 oncologists were analysed using interpretation pattern analysis combined with thematic analysis. RESULTS: Advice on CAM is seen by oncologists as an important service they provide to their patients, even though their knowledge of the subject is often limited. Many interviewees mentioned an apparent lack of scientific proof, especially when their aim was to warn patients against the use of CAM. Discussions on CAM tend to reflect the idea that CAM belongs 'to another world', and judging by the interviews with oncologists, this notion appears to be shared by patients and oncologists alike. CONCLUSIONS: Oncologists require reliable information on CAM and would profit from training in the communication of CAM treatment options to patients. Knowing scientific data on CAM would also lower barriers stemming from the view that CAM belongs 'to another world'. Under- and postgraduate education programmes should include training on how to respond to requests addressing possible CAM options.
PURPOSE: The rising use of complementary and alternative medicine (CAM) means oncologists are increasingly asked by patients to discuss CAM treatment options. However, no formal training or established standards are available on the subject. The aim of this paper was to investigate real-world discussions of CAM treatments. In particular, we wanted to learn about the values, norms and defining features that characterise oncologist-patient discussions on CAM. METHODS: Semi-standardised interviews with 17 oncologists were analysed using interpretation pattern analysis combined with thematic analysis. RESULTS: Advice on CAM is seen by oncologists as an important service they provide to their patients, even though their knowledge of the subject is often limited. Many interviewees mentioned an apparent lack of scientific proof, especially when their aim was to warn patients against the use of CAM. Discussions on CAM tend to reflect the idea that CAM belongs 'to another world', and judging by the interviews with oncologists, this notion appears to be shared by patients and oncologists alike. CONCLUSIONS: Oncologists require reliable information on CAM and would profit from training in the communication of CAM treatment options to patients. Knowing scientific data on CAM would also lower barriers stemming from the view that CAM belongs 'to another world'. Under- and postgraduate education programmes should include training on how to respond to requests addressing possible CAM options.
Entities:
Keywords:
Advice; Beliefs and values; Complementary and alternative medicine; Qualitative analysis
Authors: Kevin Yi-Lwern Yap; En Yi Kuo; Jonathan Jun Jie Lee; Wai Keung Chui; Alexandre Chan Journal: Support Care Cancer Date: 2009-09-09 Impact factor: 3.603
Authors: Lynda G Balneaves; Cody Z Watling; Emilie N Hayward; Brenda Ross; Jill Taylor-Brown; Antony Porcino; Tracy L O Truant Journal: J Natl Cancer Inst Date: 2022-01-11 Impact factor: 13.506
Authors: Stefanie M Helmer; Alizé A Rogge; Felix Fischer; Daniel Pach; Markus Horneber; Stephanie Roll; Claudia M Witt Journal: Trials Date: 2019-01-29 Impact factor: 2.279